Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
March 10, 2020 05:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Novavax, Inc. (NASDAQ:NVAX) whereby Emergent...
Cytovance Biologics to Participate in RAFT Scientific Discussion on Commercialization of Fermentation Processes
October 18, 2019 17:24 ET
|
Cytovance Biologics
OKLAHOMA CITY, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate...
Cadence Aerospace Names Vivian Martinez-Wells as Director, Business Development & Contracts, Cadence Aerospace–Aerosystems
November 26, 2018 11:00 ET
|
Cadence Aerospace
ANAHEIM, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Cadence Aerospace, a provider of highly complex aerospace components and assemblies to commercial and defense customers, announces today the...
Cadence Aerospace Appoints Darren Waltier as Director, Business Development, Cadence Aerospace—Aerostructures
November 16, 2018 13:00 ET
|
Cadence Aerospace
ANAHEIM, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Cadence Aerospace, a provider of highly complex aerospace components and assemblies to commercial and defense customers, announces today the...